An oral testosterone offer can feel more familiar than an injection. That familiarity does not answer the questions that matter most: which preparation is being prescribed, why it fits your situation, and what follow-up will accompany it.
This review looks mainly at Maximus’s oral testosterone program. The company also markets other testosterone-related approaches, so the conclusions here should not be transferred automatically to every item in its catalog. We have not enrolled, taken the medication, or independently verified the company’s outcome claims.
- The reviewed oral preparation is explicitly described as compounded.
- Promotional first-month pricing is not the continuing rate.
- Ask about meaningful outcomes and fertility, not only hormone markers.
First, give the treatment its full name
Maximus labels the oral testosterone formulation as custom compounded. Its wider catalog includes topical and injectable testosterone plus enclomiphene. A conversation about one should not substitute for an explanation of another, particularly because enclomiphene is not testosterone replacement itself.
Ask the clinician to write out the entire proposed prescription, including any combination or accompanying medicine. Then ask what each part is intended to do. Our medicine-name explainer can help you distinguish a delivery route from an ingredient and avoid comparing unlike products by the word oral alone.
Compounded does not mean FDA approved
The oral page describes US compounding pharmacies. That tells us how the provider presents its product, but it does not establish FDA approval of the finished preparation. FDA does not review compounded drugs before marketing in the same way it evaluates approved medicines.
Ask why a compounded preparation is being considered and whether an approved alternative is relevant to the clinical discussion. Confirm the dispensing pharmacy and request its product-specific directions. Do not substitute instructions from another oral testosterone brand just because both products are swallowed.
Our compounding guide explains the questions without assuming that every compounded prescription has the same purpose or risk. The clinic’s branding cannot replace the information on the actual pharmacy label.
Read ordinary pricing separately from the promotion
The oral page currently displays monthly rates of $249.99 for one month, $199.99 on a three-month plan, and $149.99 on a six-month plan. It also shows a first-month $74.99 promotion on the six-month option, followed by the ordinary $149.99 monthly rate. Dose, state, and plan differences may affect pricing.
Ask what amount is collected at enrollment and what obligation accompanies the lower monthly equivalent. Confirm whether the quote covers all required testing, interpretation, shipping, and any additional medication. We did not complete checkout, so a displayed monthly figure should not be mistaken for a verified total invoice.
A short promotion can reduce an initial expense while leaving the continuing cost unchanged. Use the payment-plan comparison to record both. The cost worksheet is most useful after unknown costs have been answered rather than silently set to zero.
A laboratory change is only part of a result
Maximus promotes hormone changes and links research associated with its programs. Ask which formulation was studied and whether the study measured symptoms, daily functioning, adverse effects, or only laboratory markers. A change in a testosterone result does not automatically answer every one of those questions.
We have not established that this oral program produces better clinical outcomes than alternatives. Nor do before-and-after laboratory figures predict how an individual will feel. Our treatment-goals guide helps you discuss the practical benefit you and your clinician would use to assess continuing care.
Keep fertility questions separate
The provider discusses maintaining fertility markers. That wording should not be interpreted as a guarantee of sperm production or a future pregnancy. Let the prescriber know about reproductive plans before selecting a long treatment commitment or assuming an additional medicine solves the issue.
The Endocrine Society recommends against initiating testosterone when near-term fertility is planned. Ask whether specialist advice or additional testing is needed for your situation. A discussion of a hormone marker is not the same thing as a personal fertility assessment, even when both appear on the same treatment page.
Ask what happens after the first order
The oral program says testing is needed before and during treatment. Ask how a result reaches the prescriber, how you receive an explanation, and what findings might change the plan. Blood pressure deserves attention too; oral administration does not remove testosterone-related safety considerations.
Bring questions about storage, meals, travel, and missed doses to the dispensing pharmacist. Follow the directions for your exact medication. If the instructions are difficult to manage, explain the problem before trying to improvise a simpler routine. Our follow-up guide covers other points to bring back to the clinician.
What the public information supports
Maximus offers a publicly described compounded oral program with visible plan-rate examples. Those facts make a formulation-specific comparison possible. They do not establish suitability, a complete personal price, or the superiority of the company’s preferred treatment strategy.
Our CoreAge Rx versus Maximus comparison shows why an identifiable treatment offer must be separated from a brand whose TRT availability is still unverified. Across providers, the same practical standard applies: identify the medicine, understand the total obligation, and have the clinician explain the monitoring and treatment goals.
Sources & reading notes
Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Checked September 20, 2026.